<?xml version='1.0' encoding='utf-8'?>
<rss version="2.0">
	<channel>
		<title>OOIR Trends: Clinical Medicine (Medicine, General &amp; Internal)</title>
		<description>Aktuelle Paper-Trends im Bereich Clinical Medicine (Medicine, General &amp; Internal) von OOIR (mit Titel und Metadaten von Crossref)</description>
		<link>https://ooir.org</link>
		<language>en-us</language>
		<pubDate>Thu, 14 Aug 2025 01:08:49 GMT</pubDate>
		<lastBuildDate>Thu, 14 Aug 2025 01:08:49 GMT</lastBuildDate>
		<item>
			<title>Aluminum-Adsorbed Vaccines and Chronic Diseases in Childhood</title>
			<link>https://doi.org/10.7326/annals-25-00997</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, General &amp; Internal
Score: 2909
Autoren: Niklas Worm Andersson, Ingrid Bech Svalgaard, Stine Skovbo Hoffmann, Anders Hviid
Journal: Annals of Internal Medicine
Veröffentlicht: 2025-07-15
DOI: 10.7326/annals-25-00997
ISSN: 0003-4819
Tag der Erhebung (OOIR): 2025-08-14</description>
			<guid isPermaLink="false">ooir-trend-10.7326/annals-25-00997-2025-08-14-1</guid>
			<pubDate>Tue, 15 Jul 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Mitochondrial Donation and Preimplantation Genetic Testing for mtDNA Disease</title>
			<link>https://doi.org/10.1056/nejmoa2415539</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, General &amp; Internal
Score: 2400
Autoren: Louise A. Hyslop, Emma L. Blakely, Magomet Aushev, Jordan Marley, Yuko Takeda, Angela Pyle, Eilis Moody, Catherine Feeney, Jan Dutton, Carol Shaw, Sarah J. Smith, Kate Craig, Charlotte L. Alston, Lisa Lister, Karina Endacott, Samantha Byerley, Helen McDermott, Kathryn Wilson, Lynne Botham, Beth Matthew, Nilendran Prathalingam, Matthew Prior, Alison Murdoch, Douglass M. Turnbull, Gavin Hudson, Meenakshi Choudhary, Robert W. Taylor, Rekha N. Pillai, Jane A. Stewart, Robert McFarland, Mary Herbert
Journal: New England Journal of Medicine
Veröffentlicht: 2025-07-31
DOI: 10.1056/nejmoa2415539
ISSN: 0028-4793
Tag der Erhebung (OOIR): 2025-08-14</description>
			<guid isPermaLink="false">ooir-trend-10.1056/nejmoa2415539-2025-08-14-2</guid>
			<pubDate>Thu, 31 Jul 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function</title>
			<link>https://doi.org/10.1001/jama.2025.12923</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, General &amp; Internal
Score: 1992
Autoren: Laura D. Baker, Mark A. Espeland, Rachel A. Whitmer, Heather M. Snyder, Xiaoyan Leng, Laura Lovato, Kathryn V. Papp, Melissa Yu, Miia Kivipelto, Ashley S. Alexander, Susan Antkowiak, Maryjo Cleveland, Claire Day, Richard Elbein, Sarah Tomaszewski Farias, Deborah Felton, Katelyn R. Garcia, Darren R. Gitelman, Sarah Graef, Marjorie Howard, Jeffrey Katula, Katherine Lambert, Olivia Matongo, Anne Marie McDonald, Valory Pavlik, Rema Raman, Stephen Salloway, Christy Tangney, Jennifer Ventrelle, Sharon Wilmoth, Benjamin J. Willliams, Rena Wing, Nancy Woolard, Maria C. Carrillo
Journal: JAMA
Veröffentlicht: 2025-07-28
Abstract: ImportanceIdentifying new interventions to slow and prevent cognitive decline associated with dementia is critical. Nonpharmacological interventions targeting modifiable risk factors are promising, relatively low-cost, accessible, and safe approaches.ObjectiveTo compare the effects of two 2-year lifestyle interventions on cognitive trajectory in older adults at risk of cognitive decline and dementia.Design, Setting, and ParticipantsSingle-blind, multicenter randomized clinical trial enrolling 2111 participants from May 2019 to March 2023 (final follow-up, May 14, 2025) at 5 clinical sites in the US. Participant inclusion criteria enriched risk of cognitive decline and included age 60 to 79 years, sedentary lifestyle, and suboptimal diet plus at least 2 additional criteria related to family history of memory impairment, cardiometabolic risk, race and ethnicity, older age, and sex.InterventionsParticipants were randomly assigned with equal probability to structured (n = 1056) or self-guided (n = 1055) interventions. Both interventions encouraged increased physical and cognitive activity, healthy diet, social engagement, and cardiovascular health monitoring, but differed in structure, intensity, and accountability.Main Outcomes and MeasuresThe primary comparison was difference between intervention groups in annual rate of change in global cognitive function, assessed by a composite measure of executive function, episodic memory, and processing speed, over 2 years.ResultsAmong the 2111 individuals enrolled (mean age, 68.2 [SD, 5.2] years; 1455 [68.9%] female), 89% completed the year 2 assessment. The mean global cognitive composite z score increased from baseline over time in both groups, with a mean rate of increase per year of 0.243 SD (95% CI, 0.227-0.258) for the structured intervention and 0.213 SD (95% CI, 0.198-0.229) for the self-guided intervention. The mean rate of increase per year was statistically significantly greater for the structured group than the self-guided group by 0.029 SD (95% CI, 0.008-0.050; P = .008). Based on prespecified secondary subgroup comparisons, the structured intervention benefit was consistent for APOE ε4 carriers and noncarriers (P = .95 for interaction) but appeared greater for adults with lower vs higher baseline cognition (P = .02 for interaction). Fewer ascertained adverse events were reported in the structured group (serious: 151; nonserious: 1091) vs the self-guided group (serious: 190; nonserious: 1225), with a positive COVID-19 test result being the most common adverse event overall and more frequent in the structured group.Conclusions and RelevanceAmong older adults at risk of cognitive decline and dementia, a structured, higher-intensity intervention had a statistically significant greater benefit on global cognition compared with an unstructured, self-guided intervention. Further investigation of functional outcomes, biomarkers, and ongoing extended follow-up will help address clinical relevance and sustainability of the observed cognitive benefits.Trial RegistrationClinicalTrials.gov Identifier: NCT03688126
DOI: 10.1001/jama.2025.12923
ISSN: 0098-7484
Tag der Erhebung (OOIR): 2025-08-14</description>
			<guid isPermaLink="false">ooir-trend-10.1001/jama.2025.12923-2025-08-14-3</guid>
			<pubDate>Mon, 28 Jul 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Mitochondrial Donation in a Reproductive Care Pathway for mtDNA Disease</title>
			<link>https://doi.org/10.1056/nejmoa2503658</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, General &amp; Internal
Score: 1714
Autoren: Robert McFarland, Louise A. Hyslop, Catherine Feeney, Rekha N. Pillai, Emma L. Blakely, Eilis Moody, Matthew Prior, Anita Devlin, Robert W. Taylor, Mary Herbert, Meenakshi Choudhary, Jane A. Stewart, Douglass M. Turnbull
Journal: New England Journal of Medicine
Veröffentlicht: 2025-07-31
DOI: 10.1056/nejmoa2503658
ISSN: 0028-4793
Tag der Erhebung (OOIR): 2025-08-14</description>
			<guid isPermaLink="false">ooir-trend-10.1056/nejmoa2503658-2025-08-14-4</guid>
			<pubDate>Thu, 31 Jul 2025 00:00:00 GMT</pubDate>
		</item>
		<item>
			<title>Reducing the Risks of Mitochondrial Disease in Children</title>
			<link>https://doi.org/10.1056/nejme2507753</link>
			<description>Feld: Clinical Medicine
Kategorie: Medicine, General &amp; Internal
Score: 1579
Autoren: Robin Lovell-Badge
Journal: New England Journal of Medicine
Veröffentlicht: 2025-07-31
DOI: 10.1056/nejme2507753
ISSN: 0028-4793
Tag der Erhebung (OOIR): 2025-08-14</description>
			<guid isPermaLink="false">ooir-trend-10.1056/nejme2507753-2025-08-14-5</guid>
			<pubDate>Thu, 31 Jul 2025 00:00:00 GMT</pubDate>
		</item>
	</channel>
</rss>